Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Synplogen

Synplogen is a company in Japan.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 6 Sep, 2023

"prospector:3163:3612539"

Katrina-Kay Pettitt

edited on 6 Sep, 2023

Edits made to:

Infobox (+1/-1 properties)

Infobox

Number of Employees (Ranges)

5 – 9

Number of Employees (Ranges)

1 – 4

Edits on 24 May, 2023

"Clean up website values by canonicalizing and removing duplicates"

edited on 24 May, 2023

Edits made to:

Infobox (+2/-2 properties)

Infobox

Official Website

https://www.synplogen.com/

https://www.synplogen.com/en/

Official Website

https://synplogen.com

https://synplogen.com/en

Edits on 16 Mar, 2023

"prospector:2473:2562104"

Katrina-Kay Pettitt

edited on 16 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

"prospector:2472:2546900"

Katrina-Kay Pettitt

edited on 16 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Edits on 22 Feb, 2023

"prospector:2317:2474823"

Katrina-Kay Pettitt

edited on 22 Feb, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Edits on 2 Aug, 2022

edited on 2 Aug, 2022

Edits made to:

Infobox (+7/-1 properties)

Infobox

Full address

1-1 Rokkodaicho Nada-ku Kobe-shi Hyogo, 657-0013 Japan0

Location

0

CEO

Sugawara Junichi

CEO

Kazuhiko Yamamoto

0

Country

0

Former CEO

Sugawara Junichi

Founded date

February 21, 2017

0

Full address

Creative Lab for Innovation in Kobe 4F 6-3-7 Minatojima-minamimachi, Chuo-ku, Kobe-shi, Hyogo 650-0047 Japan0

Location

0

Official Website

https://www.synplogen.com/en/

Edits on 16 May, 2022

"prospector:1525:713198"

Katrina-Kay Pettitt

edited on 16 May, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Is a

Edits on 12 May, 2021

"Funding autocalculation"

edited on 12 May, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Latest funding type

Corporate funding round

Edits on 10 May, 2021

Bhupendra Solanki

edited on 10 May, 2021

Edits made to:

Infobox (+1 properties)

Infobox

B2X

Edits on 3 May, 2021

"prospector:195:102955"

edited on 3 May, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Company status

Active

Edits on 1 May, 2021

edited on 1 May, 2021

Edits made to:

Infobox (+2 properties)

Infobox

Date incorporated

2017

Full address

1-1 Rokkodaicho Nada-ku Kobe-shi Hyogo, 657-0013 Japan

Edits on 19 Apr, 2021

"Funding autocalculation"

edited on 19 Apr, 2021

Edits made to:

Infobox (+2 properties)

Infobox

Latest funding round date

October 2018

Total funding amount (USD)

924,635

"Found on funding round"

edited on 19 Apr, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Investors

edited on 19 Apr, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Funding rounds

Synplogen Corporate funding round, October 2018

Edits on 19 Mar, 2021

edited on 19 Mar, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Founder

edited on 19 Mar, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Founder

edited on 19 Mar, 2021

Edits made to:

Infobox (+1 properties)

Infobox

CEO

Sugawara Junichi

edited on 19 Mar, 2021

Edits made to:

Infobox (--1 properties)

Infobox

Number of Employees (ranges)

5 – 9

edited on 19 Mar, 2021

Edits made to:

Infobox (+6 properties)

Infobox

Crunchbase

https://www.crunchbase.com/organization/synplogen

Industry

Biopharmaceutical

Location

Pitchbook

https://pitchbook.com/profiles/company/437150-17#overview

Edits on 3 Mar, 2021

approved a suggestion from Golden's AI on 3 Mar, 2021

Edits made to:

Article (+13/-13 characters)

Article

Synplogen provides a variety of services to clients including DNA synthesisDNA synthesis, DNA library development and synthesis and viral vector development for gene therapy applications.

Find more companies like Synplogen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.